Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Pharmaceutical Excipients Market: By Product, By Function, By Dosage Form, By End User and Region Forecast 2020-2031
Pharmaceutical Excipients Market: By Product, By Function, By Dosage Form, By End User and Region Forecast 2020-2031
Pharmaceutical excipients market size was valued at US$ 7.6 billion in 2024 and is expected to reach US$ 11.6 billion by 2031, growing at a significant CAGR of 6.1% from 2025-2031. Pharmaceutical excipients are combined with active pharmaceutical ingredients to produce the final dosage form of the drugs. The excipients provide bulkiness to formulation, facilitates absorption of the drug, provides stability and prevent from the drugs from denaturation, the market are cost effective, stable, feasible for handling, and inert in the nature.
The excipient is a material that has been tested for safety and is added to a medication delivery system. It is not an active pharmaceutical ingredient (API). The main functions of excipients are to protect, support, improve stability, bioavailability, patient acceptability, and aid in effectiveness. The market is made up of sales of pharmaceutical excipients and revenue earned by the company's manufacturing of these excipients. The major advantages of using excipients are improving property of wetting, increase bulkiness of drug, provides stability, and improves the organoleptic properties of the drug.
Excipients are used in a different medicinal products like capsules, tablets, oral liquids, inhalers, implants and injections among others. Factors such as patient compliance and ease in consumption forcing drug manufactures in developing a sustained release dosage formulations which contributes to the extension of shelf life of the oral drugs that adds to the high revenue anticipation of pharmaceutical excipients. However, lack of standard quality policies and regulations for excipients and safety evaluation is expected to hamper the growth of the market over the forecast period.
Study Period
2025-2031Base Year
2024CAGR
6.1%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Global pharmaceutical excipients market is driven by growing demand for oral pharmaceuticals (solid) and development of novel therapeutics because of increase in pharmaceutical industries. The combination of nanotechnology and drug formulations in excipients led the development of nano-derived liposomes, vaccines, and nano coated tablets. The global market is expected to grow at a significant CAGR over the forecast period owing to increase in utilization of parenteral products, rise in the global burden of chronic & lifestyle diseases and increasing investments by the pharmaceutical industry on the development of biologics. Good manufacturing and distribution practices for for uniform excipients, spanning regions by international regulatory authorities is set to define the market landscape of the excipient industry over the forecast period.
The global market of pharmaceutical excipients is segmented into 5 key regions, North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America followed Europe dominates in terms of the size of the excipients market globally. Emerging market like Asia-Pacific is expected to show lucrative growth opportunity owing to the availability of lower labour cost, skilled work force in and low cost of raw materials. Countries such as Brazil, India, and China are expected to be the major contributors to the growth of pharmaceutical excipients market owing to rising per capita income and most of the companies present in developed regions willing to establish manufacturing facilities in developing regions due to their low cost of manufacturing and processing.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 7.6 billion |
|
Market Size in 2031 |
US$ 11.6 billion |
|
Market CAGR |
6.1% |
|
By Product Type |
|
|
By Function |
|
|
By Dosage Form |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The pharmaceutical excipients market size was valued at US$ 7.6 billion in 2024 and is projected to grow at a CAGR of 6.1% from 2025-2031.
The market key players are Ashland Inc.(U.S.), AkzoNobel (Netherlands), The DOW Chemical Company (U.S.), Archer Daniels Midland Company(U.S.), Associated British Foods PLC (UK), Colorcon, Inc.(U.S.), BASF SE(Germany), Evonik Industries AG (Germany), Innophos Holdings Inc. (U.S.), J.M. Huber Corporation (U.S.), FMC Corporation (U.S.), Roquette Group (Nord-Pas de Calais), Croda International PLC (UK), Merck KGaA (U.S.), Lubrizol Corporation (U.S.)
| 1.Executive Summary |
| 2.Global Pharmaceutical Excipients Market Introduction |
| 2.1.Global Pharmaceutical Excipients Market - Taxonomy |
| 2.2.Global Pharmaceutical Excipients Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Function |
| 2.2.3.Dosage Form |
| 2.2.4.End User |
| 2.2.5.Region |
| 3.Global Pharmaceutical Excipients Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Pharmaceutical Excipients Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Pharmaceutical Excipients Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Inorganic Chemicals |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Organic Chemicals |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Petrochemicals |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Pharmaceutical Excipients Market By Function, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Fillers and Diluents |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Coatings |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Binders |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Disintegrants |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Flavouring Agents |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Colorants |
| 6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7.Global Pharmaceutical Excipients Market By Dosage Form, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Tablets |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Capsules |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Liquids |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Injections |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Pharmaceutical Excipients Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Biotech Companies |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Pharmaceutical Companies |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Research Institutes |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Pharmaceutical Excipients Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Pharmaceutical Excipients Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Inorganic Chemicals |
| 10.1.2.Organic Chemicals |
| 10.1.3.Petrochemicals |
| 10.2. Function Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Fillers and Diluents |
| 10.2.2.Coatings |
| 10.2.3.Binders |
| 10.2.4.Disintegrants |
| 10.2.5.Flavouring Agents |
| 10.2.6.Colorants |
| 10.2.7.Others |
| 10.3. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Tablets |
| 10.3.2.Capsules |
| 10.3.3.Liquids |
| 10.3.4.Injections |
| 10.3.5.Others |
| 10.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Biotech Companies |
| 10.4.2.Pharmaceutical Companies |
| 10.4.3.Research Institutes |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Pharmaceutical Excipients Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Inorganic Chemicals |
| 11.1.2.Organic Chemicals |
| 11.1.3.Petrochemicals |
| 11.2. Function Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Fillers and Diluents |
| 11.2.2.Coatings |
| 11.2.3.Binders |
| 11.2.4.Disintegrants |
| 11.2.5.Flavouring Agents |
| 11.2.6.Colorants |
| 11.2.7.Others |
| 11.3. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Tablets |
| 11.3.2.Capsules |
| 11.3.3.Liquids |
| 11.3.4.Injections |
| 11.3.5.Others |
| 11.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Biotech Companies |
| 11.4.2.Pharmaceutical Companies |
| 11.4.3.Research Institutes |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Pharmaceutical Excipients Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Inorganic Chemicals |
| 12.1.2.Organic Chemicals |
| 12.1.3.Petrochemicals |
| 12.2. Function Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Fillers and Diluents |
| 12.2.2.Coatings |
| 12.2.3.Binders |
| 12.2.4.Disintegrants |
| 12.2.5.Flavouring Agents |
| 12.2.6.Colorants |
| 12.2.7.Others |
| 12.3. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Tablets |
| 12.3.2.Capsules |
| 12.3.3.Liquids |
| 12.3.4.Injections |
| 12.3.5.Others |
| 12.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Biotech Companies |
| 12.4.2.Pharmaceutical Companies |
| 12.4.3.Research Institutes |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Pharmaceutical Excipients Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Inorganic Chemicals |
| 13.1.2.Organic Chemicals |
| 13.1.3.Petrochemicals |
| 13.2. Function Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Fillers and Diluents |
| 13.2.2.Coatings |
| 13.2.3.Binders |
| 13.2.4.Disintegrants |
| 13.2.5.Flavouring Agents |
| 13.2.6.Colorants |
| 13.2.7.Others |
| 13.3. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Tablets |
| 13.3.2.Capsules |
| 13.3.3.Liquids |
| 13.3.4.Injections |
| 13.3.5.Others |
| 13.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Biotech Companies |
| 13.4.2.Pharmaceutical Companies |
| 13.4.3.Research Institutes |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Pharmaceutical Excipients Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Inorganic Chemicals |
| 14.1.2.Organic Chemicals |
| 14.1.3.Petrochemicals |
| 14.2. Function Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Fillers and Diluents |
| 14.2.2.Coatings |
| 14.2.3.Binders |
| 14.2.4.Disintegrants |
| 14.2.5.Flavouring Agents |
| 14.2.6.Colorants |
| 14.2.7.Others |
| 14.3. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Tablets |
| 14.3.2.Capsules |
| 14.3.3.Liquids |
| 14.3.4.Injections |
| 14.3.5.Others |
| 14.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Biotech Companies |
| 14.4.2.Pharmaceutical Companies |
| 14.4.3.Research Institutes |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Ashland Inc.(U.S) |
| 15.2.2.AkzoNobel (Netherlands) |
| 15.2.3.The DOW Chemical Company (U.S) |
| 15.2.4.Archer Daniels Midland Company(U.S) |
| 15.2.5.Associated British Foods PLC (UK) |
| 15.2.6.Colorcon, Inc.(U.S) |
| 15.2.7.BASF SE(Germany) |
| 15.2.8.Evonik Industries AG (Germany) |
| 15.2.9.Innophos Holdings Inc. (U.S) |
| 15.2.10.J.M. Huber Corporation (U.S) |
| 15.2.11.FMC Corporation (U.S) |
| 15.2.12.Roquette Group (Nord-Pas de Calais) |
| 15.2.13.Croda International PLC (UK) |
| 15.2.14.Merck KGaA (U.S) |
| 15.2.15.Lubrizol Corporation (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.